Acadia Pharmaceuticals


Acadia Pharmaceuticals Stock Quote
$40.18 $1.57 4.1%
Price as of September 25, 2020, 4:30 p.m. EDT View Interactive ACAD Charts

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Interactive Chart

News & Analysis: Acadia Pharmaceuticals

The Fool has written over 200 articles on Acadia Pharmaceuticals.


Market Moves


Is Acadia Pharmaceuticals a Buy?

A strong Q1 performance set the tone, but commitment to its strategy will be key to drive the stock higher.

2 Biotech Stocks to Watch In 2020

Acadia Pharmaceuticals and CRISPR Therapeutics both trounced the market last year. Here's why that could continue.